These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8741575)

  • 1. Allelotype analysis in mouse hepatocellular carcinomas; frequent homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in culture.
    Miyasaka K; Fukui T; Kitagawa T
    Biol Pharm Bull; 1996 May; 19(5):683-91. PubMed ID: 8741575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in mouse liver epithelial cells in culture.
    Miyasaka K; Kawauchi S
    Biol Pharm Bull; 1996 Mar; 19(3):345-9. PubMed ID: 8924897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture.
    Miyasaka K; Ohtake K; Nomura K; Kanda H; Kominami R; Miyashita N; Kitagawa T
    Mol Carcinog; 1995 May; 13(1):37-43. PubMed ID: 7766309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines.
    Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ; Aldaz CM
    Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor.
    Raffel C; Ueki K; Harsh GR; Louis DN
    Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma.
    Piao Z; Park C; Lee JS; Yang CH; Choi KY; Kim H
    Cancer Lett; 1998 Jan; 122(1-2):201-7. PubMed ID: 9464511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion and differential expression of p16INK4a in mouse lung tumors.
    Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
    Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
    Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
    Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.
    Williamson MP; Elder PA; Shaw ME; Devlin J; Knowles MA
    Hum Mol Genet; 1995 Sep; 4(9):1569-77. PubMed ID: 8541841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
    Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
    J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA
    Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method.
    Rawnsley JD; Srivatsan ES; Chakrabarti R; Billings KR; Wang MB
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):863-7. PubMed ID: 9260553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts.
    Obata M; Lee GH; Kanda H; Kitagawa T; Ogawa K
    Mol Carcinog; 1997 May; 19(1):17-24. PubMed ID: 9180924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.
    An HX; Niederacher D; Picard F; van Roeyen C; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1996 Sep; 17(1):14-20. PubMed ID: 8889502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.